Chen Yao
Impact in
- Drug Discovery top 10%
- Genetics top 2%
- Mesenchymal stem cell research
Papers in
-
- Electronic Health Records Systems 5
-
- Meta-analysis and systematic reviews 4
- Co-authors
- Yi Yang (2 shared papers)Hongcai Shang (2 shared papers)Haibo Qiu (2 shared papers)Wenming Yao (1 shared paper)Jian Zhang (1 shared paper)Xinli Li (1 shared paper)Yu-Hui Zhang (1 shared paper)Jun Huang (1 shared paper)
- Journals
- BMJ Open (5 papers)Journal of Evidence-Based Medicine (5 papers)Trials (3 papers)The Lancet Oncology (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Chen Yao
87 papers receiving 2.6k citations
Chen Yao's Hit Papers
Peers
Comparison fields: 5 of 87
- Drug Discovery 3
- Genetics 264
- Complementary and alternative medicine 185
- Epidemiology 370
- Health Informatics 22
Countries citing papers authored by Chen Yao
This map shows the geographic impact of Chen Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Yao more than expected).
Fields of papers citing papers by Chen Yao
This network shows the impact of papers produced by Chen Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Yao. The network helps show where Chen Yao may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Yao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Epidemiology of Sepsis in Chinese ICUs: A National Cross-Sectional Survey Hit paper breakdown → | 2019 | 343 |
| 2 | Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial Hit paper breakdown → | 2021 | 313 |
| 3 | 2013 | 274 | |
| 4 | 2008 | 221 | |
| 5 | Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial Hit paper breakdown → | 2021 | 215 |
| 6 | 2015 | 184 | |
| 7 | 2019 | 133 | |
| 8 | Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction Hit paper breakdown → | 2023 | 102 |
| 9 | 2023 | 76 | |
| 10 | 2011 | 59 | |
| 11 | 2020 | 36 | |
| 12 | 2013 | 35 | |
| 13 | 2012 | 33 | |
| 14 | 2016 | 30 | |
| 15 | 2015 | 29 | |
| 16 | 2013 | 26 | |
| 17 | 2017 | 26 | |
| 18 | 2024 | 26 | |
| 19 | Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial Hit paper breakdown → | 2025 | 26 |
| 20 | 2025 | 26 |
About Chen Yao
Chen Yao is a scholar working on Health Information Management, Statistics, Probability and Uncertainty, Cardiology and Cardiovascular Medicine, Statistics and Probability and Epidemiology, having authored 92 papers that have together received 2.7k indexed citations. Recurring topics across this work include Electronic Health Records Systems (5 papers), Sepsis Diagnosis and Treatment (4 papers), Meta-analysis and systematic reviews (4 papers), Statistical Methods in Clinical Trials (4 papers), Clinical practice guidelines implementation (3 papers), Mesenchymal stem cell research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Drug Discovery (3 citations), Genetics (264 citations), Complementary and alternative medicine (185 citations), Epidemiology (370 citations) and Health Informatics (22 citations). Chen Yao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yi Yang, Hongcai Shang, Haibo Qiu, Wenming Yao, Jian Zhang, Xinli Li, Yu-Hui Zhang, Jun Huang, Zonggui Wu and Aiqun Ma. Their work appears in journals such as BMJ Open, Journal of Evidence-Based Medicine, Trials, The Lancet Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.